ArticleBMC medical imaging2026
Early detection of right atrial dysfunction assessed by MR-feature tracking in patients with arrhythmogenic right ventricular cardiomyopathy.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundThe importance of right atrial (RA) function assessment in arrhythmogenic right ventricular cardiomyopathy (ARVC) is increasingly being recognized. MR-feature tracking (MR-FT) has emerged as a novel approach for quantifying atrial function. Therefore, we aimed to evaluate whether early RA dysfunction, even without RA dilation, can be identified in patients with ARVC using MR-FT.
methodsSixty-four patients with ARVC, of whom 47 were non-RA dilated and 17 were RA dilated patients, along with 41 healthy controls were included. RA reservoir, conduit, and booster strain (εs, εe, and εa) and peak positive, early negative, and late negative strain rate (SRs, SRe, and SRa) were measured using MR-FT. Right ventricular (RV) remodeling index was calculated as the ratio of RV to left ventricular end-diastolic volumes.
resultsPatients with ARVC (both RA Dilated and non-RA Dilated group) exhibited significantly lower RA εs, εe, εa, SRs, SRe, and SRa compared to healthy controls. RA dilation patients further reduced these parameters (all P < 0.001). Among RA strain parameters, SRe showed the highest diagnostic value for RV remodeling in patients with ARVC (AUC = 0.799, 95% CI: 0.683-0.915). A strong correlation was observed between RA strain, strain rate, and RA emptying fractions in ARVC patients (P < 0.001). Intra- and inter-observer reproducibility was excellent for RA strain measurements.
conclusionPatients with ARVC exhibit impaired RA reservoir, conduit, and booster function even with normal RA volumes. MR-FT may serve as a promising approach for detecting early RA dysfunction in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.